ALXO
ALXO
NASDAQ · Biotechnology

Alx Oncology Holdings Inc

$2.01
+0.01 (+0.25%)
As of Apr 1, 3:01 PM ET ·
Financial Highlights (FY 2025)
Revenue
18.10M
Net Income
3.87M
Gross Margin
38.0%
Profit Margin
21.4%
Rev Growth
+0.2%
D/E Ratio
0.48
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 38.0% 38.0% 38.0%
Operating Margin 21.7% 26.1% 22.6%
Profit Margin 21.4% 17.3% 20.6%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 18.10M 17.71M 19.64M
Gross Profit 6.88M 6.74M 7.47M
Operating Income 3.93M 4.62M 4.43M
Net Income 3.87M 3.06M 4.04M
Gross Margin 38.0% 38.0% 38.0%
Operating Margin 21.7% 26.1% 22.6%
Profit Margin 21.4% 17.3% 20.6%
Rev Growth +0.2% -1.6% +10.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 25.58M 32.72M 30.91M
Total Equity 53.35M 49.96M 47.43M
D/E Ratio 0.48 0.65 0.65
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.83M 6.29M 6.55M
Free Cash Flow 3.85M 4.93M 3.44M